INSMED Inc
INSM· Nasdaq
INSMINSMED Inc
Filed Feb 25, 2021 · 10-K · 56 days after period end · 0001104506-21-000005
derived · Computed from the longer spans the company filed.
| Metric | Q4 2020dderived from reported figures | Q4 2019 | Q4 2018 | Q4 2017 |
|---|---|---|---|---|
| Revenue | $41.42M | $45.71M | $9.84M | $0.00 |
| Net Income | -$102.21M | -$52.99M | -$91.57M | -$65.38M |
| EPS Diluted | — | -$0.59 | -$1.19 | -$0.85 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
INSMED Inc · CIK 1104506 · Engraved from SEC EDGAR
ended Dec 31, 2020 · filed Feb 25, 2021 · 56 d after period end
